Skip to main content
SpringerLink
Log in

Endokrinologische Labordiagnostik

  • Chapter
Book cover Labormedizin

  • 1493 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Allgemein

  • Thomas L (1998) Labor und Diagnose. TH-Books Verlagsgesellschaft mbH, Frankfurt/Main

    Google Scholar 

  • Löffler G (1998) Basiswissen Biochemie mit Pathobiochemie. Springer, Berlin Heidelberg New York

    Google Scholar 

Speziell

  1. Schimmel M, Utiger R D (1977) Thyroidal and peripheral production of thyroid hormones. Review of recent findings and their clinical implications. Ann Intern Med 87(6): 760–768

    PubMed  CAS  Google Scholar 

  2. Leboulleux S, Baudin E, Travagli J P, Schlumberger M (2004) Medullary thyroid carcinoma. Clin Endocrinol (Oxf) 61(3): 299–310

    Article  Google Scholar 

  3. Whitley R J, Ain K B (2004) Thyroglobulin: a specific serum marker for the management of thyroid carcinoma. Clin Lab Med 24(1): 29–47

    Article  PubMed  Google Scholar 

  4. Derwahl M, Studer H (2001) Nodular goiter and goiter nodules: Where iodine deficiency falls short of explaining the facts. Exp Clin Endocrinol Diabetes 109(5): 250–260

    Article  PubMed  CAS  Google Scholar 

  5. Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhausl A, Niederle B (1997) Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 82(5): 1589–1593

    Article  PubMed  CAS  Google Scholar 

  6. Chadwick D R, Harrison B J (1998) The role of fine-needle aspiration cytology and frozen section histology in management of differentiated thyroid cancer: the UK experience. Langenbecks Arch Surg 383(2): 164–166

    PubMed  CAS  Google Scholar 

  7. Cooper D S (2005) Antithyroid drugs. N Engl J Med 352(9): 905–917

    Article  PubMed  CAS  Google Scholar 

  8. Biondi B, Palmieri E A, Klain M, Schlumberger M, Filetti S, Lombardi G (2005) Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol 152(1): 1–9

    Article  PubMed  CAS  Google Scholar 

  9. McLachlan S M, Rapoport B (2004) Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies? Thyroid 14(7): 510–520

    Article  PubMed  CAS  Google Scholar 

  10. Boulos P R, Hardy I (2004) Thyroid-associated orbitopathy: a clinicopathologic and therapeutic review. Curr Opin Ophthalmol 15(5): 389–400

    Article  PubMed  Google Scholar 

  11. Danzi S, Klein I (2004) Thyroid hormone and the cardiovascular system. Minerva Endocrinol 29(3): 139–150

    PubMed  CAS  Google Scholar 

  12. Meyer-Gessner M, Benker G, Lederbogen S, Olbricht T, Reinwein D (1994) Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature. J Endocrinol Invest 17(1): 29–36

    PubMed  CAS  Google Scholar 

  13. Cooper D S (2003) Hyperthyroidism. Lancet 362(9382): 459–468

    Article  PubMed  CAS  Google Scholar 

  14. Rehman H U, Bajwa T A (2004) Newly diagnosed hypothyroidism. BMJ 329(7477): 1271

    Article  PubMed  CAS  Google Scholar 

  15. Gruters A, Krude H, Biebermann H (2004) Molecular genetic defects in congenital hypothyroidism. Eur J Endocrinol 151[Suppl 3]: U39–44

    Article  PubMed  Google Scholar 

  16. Stockigt J R (2002) Case finding and screening strategies for thyroid dysfunction. Clin Chim Acta 315(1–2): 111–124

    Article  PubMed  CAS  Google Scholar 

  17. Pittman J G (1996) Evaluation of patients with mildly abnormal thyroid function tests. Am Fam Physician 54(3): 961–966

    PubMed  CAS  Google Scholar 

  18. Vitti P, Rago T (2003) Thyroid ultrasound as a predicator of thyroid disease. J Endocrinol Invest 26(7): 686–689

    PubMed  CAS  Google Scholar 

  19. Wiersinga W M (2001) Thyroid hormone replacement therapy. Horm Res 56[Suppl 1]: 74–81

    Article  PubMed  CAS  Google Scholar 

  20. Marcocci C, Marino M, Rocchi R, Menconi F, Morabito E, Pinchera A (2004) Novel aspects of immunosuppressive and radiotherapy management of Graves’ ophthalmopathy. J Endocrinol Invest 27(3): 272–280

    PubMed  CAS  Google Scholar 

  21. Su D H, Huang T S (2002) Acute suppurative thyroiditis caused by Salmonella typhimurium: a case report and review of the literature. Thyroid 12(11): 1023–1027

    Article  PubMed  Google Scholar 

  22. Klima G, Beranek M, Rothlauer W (1996) Definite distinction between thyroidal inflammatory conditions and other soft tissue inflammations of the neck using ultrasound. Acta Med Austriaca 23(1–2): 80–82

    PubMed  CAS  Google Scholar 

  23. Slatosky J, Shipton B, Wahba H (2000) Thyroiditis: differential diagnosis and management. Am Fam Physician 61(4): 1047–1052

    PubMed  CAS  Google Scholar 

  24. Lazarus J H (2005) Thyroid disorders associated with pregnancy: etiology, diagnosis, and management. Treat Endocrinol 4(1): 31–41

    Article  PubMed  Google Scholar 

  25. Chang T C, Lai S M, Wen C Y, Hsiao Y L (2004) Three-dimensional cytomorphology in fine needle aspiration biopsy of subacute thyroiditis. Acta Cytol 48(2): 155–160

    PubMed  Google Scholar 

  26. Castro M R, Gharib H (2005) Continuing controversies in the management of thyroid nodules. Ann Intern Med 142(11): 926–931

    PubMed  Google Scholar 

  27. Fernandes J K, Day T A, Richardson M S, Sharma A K (2005) Overview of the management of differentiated thyroid cancer. Curr Treat Options Oncol 6(1): 47–57

    PubMed  Google Scholar 

  28. Zimmermann M B (2004) Assessing iodine status and monitoring progress of iodized salt programs. J Nutr 134(7): 1673–1677

    PubMed  CAS  Google Scholar 

  29. Brauckhoff M, Lorenz K, Ukkat J, Brauckhoff K, Gimm O, Dralle H (2004) Medullary thyroid carcinoma. Scand J Surg 93(4): 249–260

    PubMed  CAS  Google Scholar 

  30. Stathatos N, Wartofsky L (2003) The euthyroid sick syndrome: is there a physiologic rationale for thyroid hormone treatment? J Endocrinol Invest 26(12): 1174–1179

    PubMed  CAS  Google Scholar 

  31. Lazarus J H, Premawardhana L D (2005) Screening for thyroid disease in pregnancy. J Clin Pathol 58(5): 449–452

    Article  PubMed  CAS  Google Scholar 

  32. Redmond G P (2004) Thyroid dysfunction and women’s reproductive health. Thyroid 14[Suppl 1]: S5–15

    Article  PubMed  Google Scholar 

  33. Allahabadia A, Weetman A P (2003) Dynamic thyroid stimulating hormone tests: do they still have a role? J Endocrinol Invest 26[7 Suppl]: 31–38

    PubMed  CAS  Google Scholar 

  34. Gunn I R, Gaffney D (2004) Clinical and laboratory features of calcium-sensing receptor disorders: a systematic review. Ann Clin Biochem 41(Pt 6): 441–458

    Article  PubMed  CAS  Google Scholar 

  35. Levine M A, Germain-Lee E, Jan de Beur S (2003) Genetic basis for resistance to parathyroid hormone. Horm Res 60[Suppl 3]: 87–95

    Article  PubMed  CAS  Google Scholar 

  36. Hershkovitz E, Parvari R, Diaz G A, Gorodischer R (2004) Hypoparathyroidism-retardation-Dysmorphism (HRD) syndrome—a review. J Pediatr Endocrinol Metab 17(12): 1583–1590

    PubMed  Google Scholar 

  37. Pattou F, Combemale F, Fabre S, Carnaille B, Decoulx M, Wemeau J L, Racadot A, Proye C (1998) Hypocalcemia following thyroid surgery: incidence and prediction of outcome. World J Surg 22(7): 718–724

    Article  PubMed  CAS  Google Scholar 

  38. Bilezikian J P, Brandi M L, Rubin M, Silverberg S J (2005) Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. J Intern Med 257(1): 6–17

    Article  PubMed  CAS  Google Scholar 

  39. Younes N A, Shafagoj Y, Khatib F, Ababneh M (2005) Laboratory screening for hyperparathyroidism. Clin Chim Acta 353(1–2): 1–12

    Article  PubMed  CAS  Google Scholar 

  40. Palazzo F F, Delbridge L W (2004) Minimal-access/minimally invasive parathyroidectomy for primary hyperparathyroidism. Surg Clin North Am 84(3): 717–734

    Article  PubMed  Google Scholar 

  41. Pietila K, Morsky P, Pasternack A, Mustonen J, Koivula T (1987) Intact parathyroid hormone, ionized calcium and calcium infusion test in the evaluation of hyperparathyroidism in chronic renal failure. Nephron 47(4): 284–289

    PubMed  CAS  Google Scholar 

  42. Iwasaki Y, Mutsuga N, Yamamori E, Kakita A, Oiso Y, Imai T, Funahashi H, Tanaka Y, Kondo K, Nakashima N (2003) Sodium bicarbonate infusion test: a new method for evaluating parathyroid function. Endocr J 50(5):545–551

    Article  PubMed  CAS  Google Scholar 

  43. Nemeth E F (2004) Calcimimetic and calcilytic drugs: just for parathyroid cells? Cell Calcium 35(3): 283–289

    Article  PubMed  CAS  Google Scholar 

  44. Davies M, Fraser W D, Hosking D J (2002) The management of primary hyperparathyroidism. Clin Endocrinol (Oxf) 57(2): 145–155

    Article  CAS  Google Scholar 

  45. de Francisco A L (2004) Secondary hyperparathyroidism: review of the disease and its treatment. Clin Ther 26(12): 1976–1993

    Article  PubMed  Google Scholar 

  46. Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 4: 477–501

    Article  Google Scholar 

  47. Ketteler M, Gross M L, Ritz E (2005) Calcification and cardiovascular problems in renal failure. Kidney Int [Suppl] (94): S120–127

    Article  CAS  Google Scholar 

  48. Mosekilde L (2005) Vitamin D and the elderly. Clin Endocrinol (Oxf) 62(3): 265–81

    Article  CAS  Google Scholar 

  49. Schlosser K, Zielke A, Rothmund M (2004) Medical and surgical treatment for secondary and tertiary hyperparathyroidism. Scand J Surg 93(4): 288–297

    PubMed  CAS  Google Scholar 

  50. Fernandez-Cruz L, Puig-Domingo M, Halperin I, Sesmilo G (2004) Pheochromocytoma. Scand J Surg 93(4): 302–309

    PubMed  CAS  Google Scholar 

  51. Eisenhofer G, Lenders J W, Goldstein D S, Mannelli M, Csako G, Walther M M, Brouwers F M, Pacak K (2005) Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clin Chem 51(4): 735–744

    Article  PubMed  CAS  Google Scholar 

  52. Goldstein D S, Eisenhofer G, Flynn J A, Wand G, Pacak K (2004) Diagnosis and localization of pheochromocytoma. Hypertension 43(5): 907–910

    Article  PubMed  CAS  Google Scholar 

  53. Pacak K, Ilias I, Adams K T, Eisenhofer G (2005) Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour. J Intern Med 257(1): 60–68

    Article  PubMed  CAS  Google Scholar 

  54. Davies R A, Patt N L, Sole M J (1979) Localization of pheochromocytoma by selective venous catheterization and assay of plasma catecholamines. Can Med Assoc J 120(5): 539–542

    PubMed  CAS  Google Scholar 

  55. Grossman E, Goldstein D S, Hoffman A, Keiser H R (1991) Glucagon and clonidine testing in the diagnosis of pheochromocytoma. Hypertension 17(6 Pt 1): 733–741

    PubMed  CAS  Google Scholar 

  56. Chavez-Rodriguez J, Pasieka J L (2005) Adrenal lesions assessed in the era of laparoscopic adrenalectomy: a modern day series. Am J Surg 189(5): 581–585

    Article  PubMed  CAS  Google Scholar 

  57. Maris J M (2005) The biologic basis for neuroblastoma heterogeneity and risk stratification. Curr Opin Pediatr 17(1): 7–13

    Article  PubMed  Google Scholar 

  58. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass („incidentaloma“). NIH Consens. State Sci Statements 19(2): 1–25 (2002)

    Google Scholar 

  59. Leowattana W (2004) DHEAS as a new diagnostic tool. Clin Chim Acta 341(1–2): 1–15

    Article  PubMed  CAS  Google Scholar 

  60. Beauregard C, Dickstein G, Lacroix A (2002) Classic and recent etiologies of Cushing’s syndrome: diagnosis and therapy. Treat Endocrinol 1(2): 79–94

    Article  PubMed  Google Scholar 

  61. Newell-Price J, Trainer P, Besser M, Grossman A (1998) The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 19(5): 647–672

    Article  PubMed  CAS  Google Scholar 

  62. Wajchenberg B L, Albergaria Pereira M A, Medonca B B, Latronico A C, Campos Carneiro P, Alves V A, Zerbini M C, Liberman B, Carlos Gomes G, Kirschner M A (2000) Adrenocortical carcinoma: clinical and laboratory observations. Cancer 88(4): 711–736

    Article  PubMed  CAS  Google Scholar 

  63. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein S R (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 25(2): 309–340

    Article  PubMed  Google Scholar 

  64. Sonino N, Boscaro M, Fallo F (2005) Pharmacologic management of Cushing syndrome: new targets for therapy. Treat Endocrinol 4(2): 87–94

    Article  PubMed  CAS  Google Scholar 

  65. Marzotti S, Falorni A (2004) Addison’s disease. Autoimmunity 37(4): 333–336

    Article  PubMed  CAS  Google Scholar 

  66. Ellacott K L, Cone R D (2004) The central melanocortin system and the integration of short-and long-term regulators of energy homeostasis. Recent Prog Horm Res 59: 395–408

    Article  PubMed  CAS  Google Scholar 

  67. Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23(3): 327–364

    Article  PubMed  CAS  Google Scholar 

  68. Dorin R I, Qualls C R, Crapo L M (2003) Diagnosis of adrenal insufficiency. Ann Intern Med 139(3): 194–204

    PubMed  Google Scholar 

  69. Eisenbarth G S, Gottlieb P A (2004) Autoimmune polyendocrine syndromes. N Engl J Med 350(20): 2068–2079

    Article  PubMed  CAS  Google Scholar 

  70. Kaplan N M (2004) The current epidemic of primary aldosteronism: causes and consequences. J Hypertens 22(5): 863–869

    Article  PubMed  CAS  Google Scholar 

  71. Plouin P F, Jeunemaitre X (2004) Would wider screening for primary aldosteronism give any health benefits? Eur J Endocrinol 151(3): 305–308

    Article  PubMed  CAS  Google Scholar 

  72. Miedlich S, Lohmann T, Schneyer U, Lamesch P, Paschke R (2001) Familial isolated primary hyperparathyroidism-a multiple endocrine neoplasia type 1 variant? Eur J Endocrinol 145(2): 155–160

    Article  PubMed  CAS  Google Scholar 

  73. Reincke M, Seiler L, Rump L C (2003) Normokaliämischer primärer Hyperaldosteronismus. Dtsch Äbl 100: 184–190

    Google Scholar 

  74. Croom K F, Perry C M (2005) Eplerenone: a review of its use in essential hypertension. Am J Cardiovasc Drugs 5(1): 51–69

    Article  PubMed  CAS  Google Scholar 

  75. Wiegratz I, Kuhl H (2002) Managing cutaneous manifestations of hyperandrogenic disorders: the role of oral contraceptives. Treat Endocrinol 1(6): 372–386

    Article  PubMed  Google Scholar 

  76. Ehrmann D A (2005) Polycystic ovary syndrome. N Engl J Med 352(12):1223–1236

    Article  PubMed  CAS  Google Scholar 

  77. Burger H G (2002) Androgen production in women. Fertil Steril 77[Suppl4]: S3–5

    Article  PubMed  Google Scholar 

  78. Aron D C, Howlett T A (2000) Pituitary incidentalomas. Endocrinol Metab Clin North Am 29(1): 205–221

    Article  PubMed  CAS  Google Scholar 

  79. Kaltsas G A, Nomikos P, Kontogeorgos G, Buchfelder M, Grossman A B (2005) Clinical review: Diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab 90(5): 3089–3099

    Article  PubMed  CAS  Google Scholar 

  80. Kelestimur F (2003) Sheehan’s syndrome. Pituitary 6(4): 181–188

    Article  PubMed  Google Scholar 

  81. Dickstein G (2003) The assessment of the hypothalamo-pituitary-adrenal axis in pituitary disease: are there short cuts? J Endocrinol Invest 26[7 Suppl]: 25–30

    PubMed  CAS  Google Scholar 

  82. Verhelst J, Abs R (2003) Hyperprolactinemia: pathophysiology and management. Treat Endocrinol 2(1): 23–32

    Article  PubMed  Google Scholar 

  83. Schlechte J A (2003) Clinical practice. Prolactinoma. N Engl J Med 349(21): 2035–41

    Article  PubMed  CAS  Google Scholar 

  84. Molitch M E (2002) Medical management of prolactin-secreting pituitary adenomas. Pituitary 5(2): 55–65

    Article  PubMed  CAS  Google Scholar 

  85. Grottoli S, Gasco V, Ragazzoni F, Ghigo E (2003) Hormonal diagnosis of GH hypersecretory states. J Endocrinol Invest 26[10 Suppl]: 27–35

    PubMed  CAS  Google Scholar 

  86. Arafah B M, Nasrallah M P (2001) Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer 8(4): 287–305

    Article  PubMed  CAS  Google Scholar 

  87. Muller E E, Rigamonti A E, Cella S G (2003) Mechanisms of action of GH. J Endocrinol Invest 26[10 Suppl]: 2–15

    PubMed  CAS  Google Scholar 

  88. Wass J A (2003) Dynamic testing in the diagnosis and follow-up of patients with acromegaly. J Endocrinol Invest 26[7 Suppl]: 48–53

    PubMed  CAS  Google Scholar 

  89. Grottoli S, Gasco V, Ragazzoni F, Ghigo E (2003) Hormonal diagnosis of GH hypersecretory states. J Endocrinol Invest 26[10 Suppl]: 27–35

    PubMed  CAS  Google Scholar 

  90. Arnaldi G, Angeli A, Atkinson A B, Bertagna X, Cavagnini F, Chrousos G P, Fava G A, Findling J W, Gaillard R C, Grossman A B, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman L K, Sonino N, Vance M L, Giustina A, Boscaro M (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88(12):5593–5602

    Article  PubMed  CAS  Google Scholar 

  91. Sudhakar N, Ray A, Vafidis J A (2004) Complications after trans-sphenoidal surgery: our experience and a review of the literature. Br J Neurosurg 18(5): 507–512

    PubMed  CAS  Google Scholar 

  92. Koriyama N, Nakazaki M, Hashiguchi H, Aso K, Ikeda Y, Kimura T, Eto H, Hirano H, Nakano S, Tei C (2004) Thyrotropin-producing pituitary adenoma associated with Graves’ disease. Eur J Endocrinol 151(5): 587–594

    Article  PubMed  CAS  Google Scholar 

  93. Ball S G, Barber T, Baylis P H (2003) Tests of posterior pituitary function. J Endocrinol Invest 26[7 Suppl]: 15–24

    PubMed  CAS  Google Scholar 

  94. Arafah B M (2002) Medical management of hypopituitarism in patients with pituitary adenomas. Pituitary 5(2): 109–117

    Article  PubMed  CAS  Google Scholar 

  95. Verbalis J G (2002) Management of disorders of water metabolism in patients with pituitary tumors. Pituitary 5(2): 119–132

    Article  PubMed  CAS  Google Scholar 

  96. Maghnie M (2003) Diabetes insipidus. Horm Res 59[Suppl 1]: 42–54

    Article  PubMed  CAS  Google Scholar 

  97. Bendz H, Aurell M (1999) Drug-induced diabetes insipidus: incidence, prevention and management. Drug Saf 21(6): 449–456

    Article  PubMed  CAS  Google Scholar 

  98. Ball S G, Barber T, Baylis P H (2003) Tests of posterior pituitary function. J Endocrinol Invest 26[7 Suppl]: 15–24

    PubMed  CAS  Google Scholar 

  99. Vokes T J, Robertson G L (1988) Disorders of antidiuretic hormone. Endocrinol Metab Clin North Am 17(2): 281–299

    PubMed  CAS  Google Scholar 

  100. Vachharajani T J, Zaman F, Abreo K D (2003) Hyponatremia in critically ill patients. J Intensive Care Med 18(1): 3–8

    Article  PubMed  CAS  Google Scholar 

  101. Baylis P H (2003) The syndrome of inappropriate antidiuretic hormone secretion. Int J Biochem Cell Biol 35(11): 1495–1499

    Article  PubMed  CAS  Google Scholar 

  102. Seibel M J (2003) Biochemical markers of bone metabolism in the assessment of osteoporosis: useful or not? J Endocrinol Invest 26(5): 464–471

    PubMed  CAS  Google Scholar 

  103. Christodoulou C, Cooper C (2003) What is osteoporosis? Postgrad Med J 79(929): 133–138

    Article  PubMed  CAS  Google Scholar 

  104. Inaba M (2004) Secondary osteoporosis: thyrotoxicosis, rheumatoid arthritis, and diabetes mellitus. J Bone Miner Metab 22(4): 287–292

    Article  PubMed  Google Scholar 

  105. Sattler A M, Schoppet M, Schaefer J R, Hofbauer L C (2004) Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease. Calcif Tissue Int 74(1): 103–106

    Article  PubMed  CAS  Google Scholar 

  106. Crandall C (2003) Laboratory workup for osteoporosis. Which tests are most cost-effective? Postgrad Med J 114(3): 35–38, 41–44

    Google Scholar 

  107. Obermayer-Pietsch B M, Bonelli C M, Walter D E, Kuhn R J, Fahrleitner-Pammer A, Berghold A, Goessler W, Stepan V, Dobnig H, Leb G, Renner W (2004) Genetic predisposition for adult lactose intolerance and relation to diet, bone density, and bone fractures. J Bone Miner Res 19(1): 42–47

    Article  PubMed  Google Scholar 

  108. Felsenberg D, Boonen S (2005) The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin Ther 27(1): 1–11

    Article  PubMed  Google Scholar 

  109. Stepan J J (2003) Clinical utility of bone markers in the evaluation and follow-up of osteoporotic patients: why are the markers poorly accepted by clinicians? J Endocrinol Invest 26(5): 458–463

    PubMed  CAS  Google Scholar 

  110. Hammett-Stabler C A (2004) The use of biochemical markers in osteoporosis. Clin Lab Med 24(1): 175–197

    Article  PubMed  Google Scholar 

  111. Bielesz B, Klaushofer K, Oberbauer R (2004) Renal phosphate loss in hereditary and acquired disorders of bone mineralization. Bone 35(6):1229–1239

    Article  PubMed  CAS  Google Scholar 

  112. Holick M F (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80[6 Suppl]: 1678S–1688S

    PubMed  CAS  Google Scholar 

  113. Malluche H H, Langub M C, Monier-Faugere M C (1999) The role of bone biopsy in clinical practice and research. Kidney Int [Suppl 73]: S20–25

    Article  Google Scholar 

  114. Roodman G D, Windle J J (2005) Paget disease of bone. Clin Invest 115(2): 200–208

    Article  CAS  Google Scholar 

  115. Fohr B, Dunstan C R, Seibel M J (2003) Clinical review 165: Markers of bone remodeling in metastatic bone disease. J Clin Endocrinol Metab 88(11): 5059–5075

    Article  PubMed  CAS  Google Scholar 

  116. Bukulmez O, Arici A (2004) Assessment of ovarian reserve. Curr Opin Obstet Gynecol 16(3): 231–237

    PubMed  Google Scholar 

  117. Ehrmann D A (2005) Polycystic ovary syndrome. N Engl J Med 52(12):1223–1236

    Article  Google Scholar 

  118. McCann S M, Karanth S, Mastronardi C A, Dees W L, Childs G, Miller B, Sower S, Yu W H (2001) Control of gonadotropin secretion by follicle-stimulating hormone-releasing factor, luteinizing hormone-releasing hormone, and leptin. Arch Med Res 2(6): 476–485

    Article  Google Scholar 

  119. Moretti C, Toscano V (2003) Dynamic evaluation of ovarian reserve and abnormal androgen excess in women. J Endocrinol Invest 6[7 Suppl]: 114–123

    Google Scholar 

  120. McLachlan R I, Allan C A (2004) Defining the prevalence and incidence of androgen deficiency in aging men: where are the goal posts? J Clin Endocrinol Metab 9(12): 5916–5919

    Article  CAS  Google Scholar 

  121. Liu P Y, Swerdloff R S, Veldhuis J D (2004) Clinical review 171: The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. J Clin Endocrinol Metab 9(10): 4789–4796

    Article  CAS  Google Scholar 

  122. Byrne M, Nieschlag E (2003) Testosterone replacement therapy in male hypogonadism. J Endocrinol Invest 6(5): 481–489

    Google Scholar 

  123. Badenhoop K, Boehm B O (2004) Genetic susceptibility and immunological synapse in type 1 diabetes and thyroid autoimmune disease. Exp Clin Endocrinol Diabetes 12(8): 407–415

    Article  Google Scholar 

  124. Thakker R V (2004) Diseases associated with the extracellular calcium-sensing receptor. Cell Calcium 5(3): 275–282

    Article  CAS  Google Scholar 

  125. Miedlich S, Krohn K, Paschke R (2003) Update on genetic and clinical aspects of primary hyperparathyroidism. Clin Endocrinol (Oxf) 59(5):539–54

    Article  CAS  Google Scholar 

  126. Marx S J (2005) Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nat Rev Cancer 5(5): 367–375

    Article  PubMed  CAS  Google Scholar 

  127. Stratakis C A, Kirschner L S (1998) Clinical and genetic analysis of primary bilateral adrenal diseases (micro-and macronodular disease) leading to Cushing syndrome. Horm Metab Res 30(6–7): 456–463

    Article  PubMed  CAS  Google Scholar 

  128. Connell J M, Fraser R, MacKenzie S M, Friel E C, Ingram M C, Holloway C D, Davies E (2004) The impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulation. Mol Cell Endocrinol 217(1–2): 243–247

    Article  PubMed  CAS  Google Scholar 

  129. Keavney B, Mayosi B, Gaukrodger N, Imrie H, Baker M, Fraser R, Ingram M, Watkins H, Farrall M, Davies E, Connell J (2005) Genetic variation at the locus encompassing 11-beta hydroxylase and aldosterone synthase accounts for heritability in cortisol precursor (11-deoxycortisol) urinary metabolite excretion. J Clin Endocrinol Metab 90(2): 1072–1077

    Article  PubMed  CAS  Google Scholar 

  130. Trakakis E, Laggas D, Salamalekis E, Creatsas G (2005) 21-Hydroxylase deficiency: from molecular genetics to clinical presentation. J Endocrinol Invest 28(2): 187–192

    PubMed  CAS  Google Scholar 

  131. Drange M R, Melmed S (1999) Molecular pathogenesis of acromegaly. Pituitary 2(1): 43–50

    Article  PubMed  CAS  Google Scholar 

  132. Namihira H, Sato M, Murao K, Cao W M, Matsubara S, Imachi H, Niimi M, Dobashi H, Wong N C, Ishida T (2002) The multiple endocrine neoplasia type 1 gene product, menin, inhibits the human prolactin promoter activity. J Mol Endocrinol 29(3): 297–304

    Article  PubMed  CAS  Google Scholar 

  133. Ralston S H (2005) Genetic determinants of osteoporosis. Curr Opin Rheumatol 17(4): 475–479

    Article  PubMed  Google Scholar 

  134. Andrew T, Antioniades L, Scurrah K J, Macgregor A J, Spector T D (2005) Risk of wrist fracture in women is heritable and is influenced by genes that are largely independent of those influencing BMD. J Bone Miner Res 20(1): 67–74

    Article  PubMed  Google Scholar 

  135. Ioannidis J P, Ralston S H, Bennett S T, Brandi M L, Grinberg D, Karassa F B, Langdahl B, van Meurs J B, Mosekilde L, Scollen S, Albagha O M, Bustamante M, Carey A H, Dunning A M, Enjuanes A, van Leeuwen J P, Mavilia C, Masi L, McGuigan F E, Nogues X, Pols H A, Reid D M, Schuit S C, Sherlock R E, Uitterlinden A G (2004) GENOMOS Study. Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA 292(17): 2105–2114

    Article  PubMed  CAS  Google Scholar 

  136. Escobar-Morreale H F, Luque-Ramirez M, San Millan J L (2005) The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev 26(2): 251–282

    Article  PubMed  CAS  Google Scholar 

  137. Zinn A R, Ramos P, Elder F F, Kowal K, Samango-Sprouse C, Ross J L (2005) Androgen receptor CAGn repeat length influences phenotype of 47, XXY (Klinefelter) syndrome. J Clin Endocrinol Metab 90(9): 5041–5046

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinische Abteilung für Endokrinologie & Nuklearmedizin, Medizinische Universitätsklinik Graz, Auenbruggerplatz 15, 8036, Graz

    B. Obermayer-Pietsch (ao. Univ. Prof. Dr.)

Authors
  1. B. Obermayer-Pietsch
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag/Wien

About this chapter

Cite this chapter

Obermayer-Pietsch, B. (2006). Endokrinologische Labordiagnostik. In: Labormedizin. Springer, Vienna. https://doi.org/10.1007/3-211-35112-4_15

Download citation

  • DOI: https://doi.org/10.1007/3-211-35112-4_15

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-25291-8

  • Online ISBN: 978-3-211-35112-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation